info on semaglutide FDA Approves Oral Semaglutide: First GLP-1 Weight Loss Pill Should I take semaglutide to

Less common but serious concerns - Acute pancreatitis has been reported with GLP-1 RAs

Comparison Table: Retatrutide vs Tirzepatide Side Effects and Safety Profile Common Side Effects (Both Medications) Both tirzepatide and retatrutide share a similar gastrointestinal side effect profile, which is characteristic of incretin-based therapies: Nausea (most common, typically transient) Diarrhea Constipation Vomiting Decreased appetite Abdominal discomfort Fatigue These effects are generally mild to moderate and tend to diminish as the body adjusts to the medication, particularly when doses are titrated gradually

In clinical trials, the weight loss curve is not a straight line

If youre not having those ongoing visits, its very hard to do this properly I think. The doctor stated GLP-1s are not a one-size-fits-all solution, adding it is important that physicians, caregivers, and parents agree to promote a healthy diet over a restrictive diet, particularly for younger patients taking the medications.

Nausea and vomiting appear to be most common when people overeat or potentially overeat fat which also slows down gastric emptying and could further worsen symptoms